67Cu-SAR-bisPSMA and enzalutamide pair is perfect !!!
fantastic news !!!
- Forums
- ASX - By Stock
- Ann: First patient treated in the Phase II of the SECuRE trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
4.13%
!
$2.27

67Cu-SAR-bisPSMA and enzalutamide pair is perfect !!! fantastic...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.27 |
Change
0.090(4.13%) |
Mkt cap ! $731.0M |
Open | High | Low | Value | Volume |
$2.18 | $2.30 | $2.17 | $2.943M | 1.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 94956 | $2.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.28 | 103561 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 90538 | 2.270 |
13 | 41510 | 2.260 |
14 | 62912 | 2.250 |
12 | 44029 | 2.240 |
10 | 104491 | 2.230 |
Price($) | Vol. | No. |
---|---|---|
2.280 | 50027 | 10 |
2.290 | 25817 | 13 |
2.300 | 87662 | 19 |
2.310 | 40265 | 9 |
2.320 | 68246 | 13 |
Last trade - 12.04pm 19/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online